Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16786134rdf:typepubmed:Citationlld:pubmed
pubmed-article:16786134lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C1710548lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:16786134lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:16786134pubmed:issue1lld:pubmed
pubmed-article:16786134pubmed:dateCreated2006-6-20lld:pubmed
pubmed-article:16786134pubmed:abstractTextThe prevalence of BRAFT1799A mutation in papillary thyroid carcinomas (PTCs) displays a marked age association: relatively high in adults and exceedingly low in childhood. We report a case of a 12-year-old Japanese female with PTC, the only one case that harbored BRAFT1799A mutation in a series of 46 childhood thyroid cancer tissues. On histology, the findings were so atypical that pathologists had repeatedly examined tumor sections to agree on the diagnosis of poorly differentiated follicular carcinoma. Upon molecular investigation, BRAFT1799A was detected in DNA extracted from paraffin-embedded material, whereas TP53 was wild-type. Since BRAFT1799A is strictly limited to PTCs, immunohistochemical staining for CD15, a specific marker for papillary carcinoma, was performed to verify the diagnosis. A small tumor area with papillary-like structure was stained positive. These findings strongly suggest that this case is a poorly differentiated carcinoma that arose from PTC and implies a possible association of BRAF mutation with dedifferentiated phenotype of PTCs.lld:pubmed
pubmed-article:16786134pubmed:languageenglld:pubmed
pubmed-article:16786134pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:citationSubsetIMlld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16786134pubmed:statusMEDLINElld:pubmed
pubmed-article:16786134pubmed:monthJullld:pubmed
pubmed-article:16786134pubmed:issn1021-335Xlld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:ItoMasahiroMlld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:OhtsuruAkiraAlld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:YamashitaShun...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:ItoKoichiKlld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:SuginoKiminor...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:NambaHiroyuki...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:MitsutakeNori...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:SaenkoVladimi...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:KumagaiAtsush...lld:pubmed
pubmed-article:16786134pubmed:authorpubmed-author:NohJaeduk...lld:pubmed
pubmed-article:16786134pubmed:issnTypePrintlld:pubmed
pubmed-article:16786134pubmed:volume16lld:pubmed
pubmed-article:16786134pubmed:ownerNLMlld:pubmed
pubmed-article:16786134pubmed:authorsCompleteYlld:pubmed
pubmed-article:16786134pubmed:pagination123-6lld:pubmed
pubmed-article:16786134pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:meshHeadingpubmed-meshheading:16786134...lld:pubmed
pubmed-article:16786134pubmed:year2006lld:pubmed
pubmed-article:16786134pubmed:articleTitleChildhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation.lld:pubmed
pubmed-article:16786134pubmed:affiliationDepartment of Molecular Medicine, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.lld:pubmed
pubmed-article:16786134pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16786134pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:16786134pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:673entrezgene:pubmedpubmed-article:16786134lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16786134lld:entrezgene
lhgdn:association:16514lhgdn:found_inpubmed-article:16786134lld:lhgdn